Human Fatty Liver Disease: Old Questions and New Insights

Cited by (1,007)

Items 201–300 of 1,007

1. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation
   Thuc T. Le, Amy J. Ziemba, Yasuyo Urasaki, Eugene D Hayes, Steven J. Brotman, Giuseppe Pizzorno · 2013 · Journal of Lipid Research
2. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
   Xu Zhang, Xuetao Ji, Qian Wang, John Zhong Li · 2017 · Protein & Cell
3. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
   Robert Nathaniel Helsley, Venkateshwari Varadharajan, Amanda L. Brown, Anthony D. Gromovsky, Rebecca C. Schugar, Iyappan Ramachandiran, Kevin Fung, Mohammad Nasser Kabbany, Rakhee Banerjee, Chase K. A. Neumann et al. · 2019 · eLife
4. Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
   Jennifer C. Price, Eric C. Seaberg, Rachel Latanich, Matthew Jay Budoff, Lawrence Kingsley, Frank Joseph Palella, Mallory D. Witt, Wendy S. Post, Chloe L. Thio · 2014 · The American Journal of Gastroenterology
5. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα
   Yan Lü, Xing Liu, Yang Jiao, Xuelian Xiong, E Wang, Xiaolin Wang, Zhijian Zhang, Huijie Zhang, Lingling Pan, Youfei Guan et al. · 2014 · Journal of Clinical Investigation
6. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
   Lonardo, Amedeo, Suzuki, Ayako · 2020 · Journal of Clinical Medicine
7. miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
   Geula Hanin, Nadav Yayon, Yonat Tzur, Rotem Haviv, Estelle R. Bennett, Shiran Udi, Yoganathan R Krishnamoorthy, Eleni Kotsiliti, Rivka Zangen, Ben Efron et al. · 2017 · Gut
8. Nutritional therapy for nonalcoholic fatty liver disease
   Paola Dongiovanni, Claudia Lanti, Patrizia Riso, Luca V. C. Valenti · 2015 · The Journal of Nutritional Biochemistry
9. Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
   Yunfei Luo, Hui Lin · 2020 · Immunity Inflammation and Disease
10. Lysine acetylation in obesity, diabetes and metabolic disease
    Abishek Iyer, David P. Fairlie, Lindsay Brown · 2011 · Immunology and Cell Biology
11. A Liver-Selective LXR Inverse Agonist That Suppresses Hepatic Steatosis
    Kristine Griffett, Laura A. Solt, Bahaa Elgendy, Theodore M. Kamenecka, Thomas P. Burris · 2012 · ACS Chemical Biology
12. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
    Xinlu Yuan, Jie Wang, Xiaoyan Tang, Yixue Li, Pu Xia, Xin Gao · 2015 · Journal of Translational Medicine
13. CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism
    Jonathan M. Peterson, Marcus M Seldin, Zhikui Wei, Susan M. Aja, Guang William Wong · 2013 · American Journal of Physiology-Gastrointestinal and Liver Physiology
14. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
    Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato · 2018 · Advanced Drug Delivery Reviews
15. Role of miR-223 in the pathophysiology of liver diseases
    Dan Ye, Tianbao Zhang, Guohua Lou, Yanning Liu · 2018 · Experimental & Molecular Medicine
16. Ultrasonographically Detected Non-Alcoholic Fatty Liver Disease Is an Independent Predictor for Identifying Patients With Insulin Resistance in Non-Obese, Non-Diabetic Middle-Aged Asian Adults
    Dong Hyun Sinn, Geum‐Youn Gwak, Ha Na Park, Jee Eun Kim, Yang Won Min, Kwang Min Kim, Yu Jin Kim, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh et al. · 2011 · The American Journal of Gastroenterology
17. Disruption of the Selenocysteine Lyase-Mediated Selenium Recycling Pathway Leads to Metabolic Syndrome in Mice
    Lucia A. Seale, Ann C. Hashimoto, Suguru Kurokawa, Christy L. Gilman, Ali Seyedali, Frederick P. Bellinger, Arjun V. Raman, Marla J. Berry · 2012 · Molecular and Cellular Biology
18. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
    Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica, Amedeo Lonardo · 2015 · Expert Review of Gastroenterology & Hepatology
19. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator–Activated Receptor α
    Xuqing Chen, Feifei Zhang, Qi Gong, Aoyuan Cui, Shu Zhuo, Zhimin Hu, Yamei Han, Jing Gao, Yixuan Sun, Zhengshuai Liu et al. · 2016 · Diabetes
20. Nonalcoholic fatty liver disease and obstructive sleep apnea
    Judith Aron‐Wisnewsky, Karine Clément, Jean‐Louis Pépin · 2016 · Metabolism
21. Metabolic profiling of fatty liver in young and middle‐aged adults: Cross‐sectional and prospective analyses of the Young Finns Study
    Jari Kaikkonen, Peter Würtz, Emmi Suomela, Miia Lehtovirta, Antti J. Kangas, Antti Jula, Vera Mikkilä, Jorma S.A. Viikari, Markus Juonala, Tapani Rönnemaa et al. · 2016 · Hepatology
22. Apolipoprotein A-IV Expression in Mouse Liver Enhances Triglyceride Secretion and Reduces Hepatic Lipid Content by Promoting Very Low Density Lipoprotein Particle Expansion
    Melissa VerHague, Dongmei Cheng, Richard B. Weinberg, Gregory S. Shelness · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
23. How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
    Duarte, Nádia, Coelho, Inês C., Patarrão, Rita S., Almeida, Joana I., Penha-Gonçalves, Carlos, Macedo, M. Paula · 2015 · BioMed Research International
24. The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease
    Marialena Mouzaki, Johane P. Allard · 2012 · Journal of Clinical Gastroenterology
25. Obstructive Sleep Apnea Syndrome and Metabolic Diseases
    Min Li, Xiaoying Li, Yan Lü · 2018 · Endocrinology
26. Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis
    Hangyu Li, Siyu Huang, Dan-Dan Zhou, Ruo-Gu Xiong, Min Luo, Adila Saimaiti, Mu-Ke Han, Ren‐You Gan, Huilian Zhu, Hua‐Bin Li · 2023 · Journal of Advanced Research
27. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
    Pi‐Xiao Wang, Xiao‐Jing Zhang, Pengcheng Luo, Xi Jiang, Peng Zhang, Junhong Guo, Guang‐Nian Zhao, Xue‐Yong Zhu, Yan Zhang, Sijun Yang et al. · 2016 · Nature Communications
28. SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity
    Fan Yin, Fan Feng, Lei Wang, Xiaoning Wang, Zongwei Li, Yu Wen Cao · 2019 · Cell Death and Disease
29. Regulation of lipid metabolism by p53 – fighting two villains with one sword
    Ido Goldstein, Varda Rotter · 2012 · Trends in Endocrinology and Metabolism
30. Role of bile acids in inflammatory liver diseases
    Evangelakos, Ioannis, Heeren, Joerg, Verkade, Esther, Kuipers, Folkert · 2021 · Seminars in Immunopathology
31. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
    Naoki Tanaka, Shogo Takahashi, Yuan Zhang, Kristopher W. Krausz, Philip B. W. Smith, Andrew D. Patterson, Frank J. Gonzalez · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
32. Iron Metabolism in Nonalcoholic Fatty Liver Disease
    James E. Nelson, Heather M. Klintworth, Kris V. Kowdley · 2011 · Current Gastroenterology Reports
33. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats
    Yupei Zhang, Kairui Tang, Yuanjun Deng, Runsen Chen, Liang Shu, Huijun Xie, Yifang He, Yanning Chen, Qinhe Yang · 2018 · Biomedicine & Pharmacotherapy
34. Structure and catalytic mechanism of a human triacylglycerol-synthesis enzyme
    Sui, Xuewu, Wang, Kun, Gluchowski, Nina L., Elliott, Shane D., Liao, Maofu, Walther, Tobias C., Farese, Robert V. · 2020 · Nature
35. Early Life Exposure to Maternal Insulin Resistance Has Persistent Effects on Hepatic NAFLD in Juvenile Nonhuman Primates
    Stephanie R. Wesolowski, Karalee C. Baquero, Sean Alec Newsom, Karim Christian El Kasmi, Bryan C. Bergman, Gerald I. Shulman, Kevin L. Grove, Jacob E. Friedman · 2014 · Diabetes
36. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes
    Alexander Yang, Emilio P. Mottillo, Ljiljana Mladenovic-Lucas, Zhou Li, James G. Granneman · 2019 · Nature Metabolism
37. Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders
    Stephen L. Pinkosky, Pieter H.E. Groot, Narendra D. Lalwani, Gregory R. Steinberg · 2017 · Trends in Molecular Medicine
38. MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice
    Ashley M. Miller, Derek S. Gilchrist, Jagtar Singh Nijjar, Elisa Araldi, Cristina M. Ramírez, Christopher A. Lavery, Carlos F Fernandez-Hernando, Iain B. McInnes, Mariola Kurowska‐Stolarska · 2013 · PLoS ONE
39. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice
    Jiansheng Huang, Yuzhi Jia, Tao Fu, Navin Viswakarma, Liang Bai, Mahendra S. Rao, Yijun Zhu, Jayme Borensztajn, Janardan K. Reddy · 2011 · The FASEB Journal
40. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
    Wei Jiang, Meihua Guo, Xin Hai · 2016 · World Journal of Gastroenterology
41. Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
    Mohammad Zarei, Emma Barroso, Xavier Palomer, Jianli Dai, Patricia Rada, Tania Quesada‐López, Joan Carles Escolá‐Gil, Lídia Cedó, Mohammad Reza Zali, Mahsa Molaei et al. · 2017 · Molecular Metabolism
42. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
    Rohit Seth Loomba, Erin S. Morgan, Lynnetta M. Watts, Shuting Xia, Lisa A. Hannan, Richard S. Geary, Brenda F. Baker, Sanjay Bhanot · 2020 · The Lancet. Gastroenterology & hepatology
43. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice
    Virginia L. Malloy, Carmen E. Perrone, Dwight A.L. Mattocks, Gene P. Ables, Nicholas S. Caliendo, David S. Orentreich, Norman Orentreich∥ · 2013 · Metabolism
44. Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice
    Singh, Abhishek K., Chaube, Balkrishna, Zhang, Xinbo, Sun, Jonathan, Citrin, Kathryn M., Canfrán-Duque, Alberto, Aryal, Binod, Rotllan, Noemi, Varela, Luis, Lee, Richard G. et al. · 2021 · Journal of Clinical Investigation
45. Genetics of nonalcoholic fatty liver disease
    Paola Dongiovanni, Luca V. C. Valenti · 2015 · Metabolism
46. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
    Dong Hyun Sinn, Soo Jin Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyun‐Kyoung Kim, Byoung-Kee Yi, Seung Woon Paik, Eliseo Güallar, Juhee Cho et al. · 2016 · Gastroenterology
47. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha
    Nina Graffmann, Sarah Ring, Marie-Ann Kawala, Wasco Wruck, Audrey Ncube, Hans‐Ingo Trompeter, James Adjaye · 2016 · Stem Cells and Development
48. Adipose Tissue-Derived Stem Cells As A Regenerative Therapy for A Mouse Steatohepatitis-Induced Cirrhosis Model
    Akihiro Seki, Yoshio Sakai, Takuya Komura, Alessandro Nasti, Keiko Yoshida, Mami Higashimoto, Masao Honda, Soichiro Usui, Masayuki Takamura, Toshinari Takamura et al. · 2013 · Hepatology
49. SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis
    Xu, Fen, Li, Zhuo, Zheng, Xiaobin, Liu, Hongxia, Liang, Hua, Xu, Haixia, Chen, Zonglan, Zeng, Kejing, Weng, Jianping · 2014 · Diabetes
50. Autophagy Deficiency by Hepatic FIP200 Deletion Uncouples Steatosis From Liver Injury in NAFLD
    Di Ma, Matthew M. Molusky, Jianrui Song, Chun-Rui Hu, Fang Fang, Crystal Rui, Anna Vachaparampil Mathew, Subramaniam Pennathur, Fei Liu, Ji‐Xin Cheng et al. · 2013 · Molecular Endocrinology
51. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
    Norbert Stefan, Markus Ramsauer, Paul Jordan, Bettina Nowotny, Kοnstantinos Kantartzis, Jürgen Machann, Jonghee Hwang, P. Nowotny, SABINE KAHL, Jürgen Harreiter et al. · 2014 · The Lancet Diabetes & Endocrinology
52. Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
    Tuulia Hyötyläinen, Livnat Jerby‐Arnon, Elina M. Petäjä, Ismo Matias Mattila, Sirkku E. Jäntti, Petri Auvinen, Amalia Gastaldelli, Hannele Yki‐Järvinen, Eytan Ruppin, Matej Orešič · 2016 · Nature Communications
53. PNPLA3 mediates hepatocyte triacylglycerol remodeling
    Hanna Ruhanen, Julia Perttilä, Maarit Hölttä‐Vuori, You Zhou, Hannele Yki‐Järvinen, Elina Ikonen, Reijo Käkelä, Vesa M. Olkkonen · 2014 · Journal of Lipid Research
54. Acyl-CoA:diacylglycerol acyltransferase: Properties, physiological roles, metabolic engineering and intentional control
    Guanqun Chen, John L. Harwood, M. Joanne Lemieux, Scot J. Stone, Randall J. Weselake · 2022 · Progress in Lipid Research
55. Oral Exposure to Silver Nanoparticles or Silver Ions May Aggravate Fatty Liver Disease in Overweight Mice
    Jianbo Jia, Feifei Li, Hongyu Zhou, Yuhong Bai, Sijin Liu, Yiguo Jiang, Guibin Jiang, Bing Yan · 2017 · Environmental Science & Technology
56. Role of aramchol in steatohepatitis and fibrosis in mice
    Marta Iruarrizaga‐Lejarreta, Marta Varela‐Rey, David Fernández‐Ramos, Ibon Martínez‐Arranz, Teresa C. Delgado, Jorge Simón, Virginia Gutiérrez‐de Juan, Laura delaCruz‐Villar, Mikel Azkargorta, José Luis Lavín et al. · 2017 · Hepatology Communications
57. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD
    Peter M. Graffy, Perry Joseph Pickhardt · 2016 · British Journal of Radiology
58. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice
    Takashi Honda, Masatoshi Ishigami, Fangqiong Luo, Ma Lingyun, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Isao Nakano, Tetsuya Ishikawa, Guo‐Gang Feng et al. · 2017 · Metabolism
59. Long-Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic Steatosis
    Hedwig S. Kruitwagen, Loes A. Oosterhoff, Ingrid G.W.H. Vernooij, Ingrid M. Schrall, Monique E. van Wolferen, Farah Bannink, Camille Roesch, Lisa van Uden, Martijn R. Molenaar, J. Bernd Helms et al. · 2017 · Stem Cell Reports
60. Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis
    Julia Starmann, Maria Fälth, Walter Spindelboeck, Katja-Lauren Lanz, Carolin Lackner, Kurt Zatloukal, Michael A Trauner, Holger Sültmann · 2012 · PLoS ONE
61. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
    Anna Alisi, Ariel E. Feldstein, Alberto Villani, Massimiliano Raponi, Valério Nobili · 2012 · Nature Reviews Gastroenterology & Hepatology
62. Modeling human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system
    Wang, Yaqing, Wang, Hui, Deng, Pengwei, Tao, Tingting, Liu, Haitao, Wu, Shuo, Chen, Wenwen, Qin, Jianhua · 2020 · ACS Biomaterials Science & Engineering
63. Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice
    Zhikui Wei, Xia Lei, Pia Steen Petersen, Susan M. Aja, Guang William Wong · 2014 · American Journal of Physiology-Endocrinology and Metabolism
64. Hypoxia and fatty liver
    Tomohiro Suzuki · 2014 · World Journal of Gastroenterology
65. Diet as an Exposure Source and Mediator of Per- and Polyfluoroalkyl Substance (PFAS) Toxicity
    Katherine Roth, Zunaira Imran, Wanqing Liu, Michael C. Petriello · 2020 · Frontiers in Toxicology
66. Perinatal exposure to bisphenol A exacerbates nonalcoholic steatohepatitis-like phenotype in male rat offspring fed on a high-fat diet.
    Jie Wei, Xia Sun, Ya-Jie Chen, Yuan-Yuan Li, Liqiong Song, Zhao Zhou, Bing Xu, Yi Lin, Shunqing Xu · 2014 · Journal of Endocrinology
67. Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential
    Dongdong Wu, Nai-rui Zheng, Kunqing Qi, Huijun Cheng, Ziqiang Sun, Biao Gao, Youjing Zhang, Wuyan Pang, Chaoshen Huangfu, Shaoping Ji et al. · 2015 · Medical Gas Research
68. Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
    Rainer Lehmann, Holger Franken, Sascha Dammeier, Lars Rosenbaum, Kοnstantinos Kantartzis, Andreas Peter, Andreas Zell, Patrick Adam, Jia Li, Guowang Xu et al. · 2013 · Diabetes Care
69. Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine
    Mazen Noureddin, José María Mato, Shelly Chi-Loo Lu · 2015 · Experimental Biology and Medicine
70. Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation
    Wang, Xing-Chun · 2014 · World Journal of Gastroenterology
71. Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target
    Michael A. Fuchs · 2011 · Journal of Lipids
72. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder
    Junjian Hu, Hongwu Wang, Xitang Li, Yonggang Liu, Yuqiang Mi, Hongyan Kong, Xi Dong, Weiming Yan, Xiaoping Luo, Qin Ning et al. · 2020 · Theranostics
73. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
    Huazhong Ying, Yuehuan Liu, Bing Yu, Zhiyuan Wang, Jia-Na Zang, Chen-Huan Yu · 2012 · Food and Chemical Toxicology
74. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice
    Hung‐Yu Lin, Feng‐Sheng Wang, Ya‐Ling Yang, Ying‐Hsien Huang · 2019 · Cells
75. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet
    Volodymyr Tryndyak, John R. Latendresse, Beverly A. Montgomery, Sharon A. Ross, Frederick A. Beland, Ivan Rusyn, Igor P. Pogribny · 2012 · Toxicology and Applied Pharmacology
76. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease
    Moreno-Fernandez, Maria E., Giles, Daniel A., Stankiewicz, Traci E., Sheridan, Rachel, Karns, Rebekah, Cappelletti, Monica, Lampe, Kristin, Mukherjee, Rajib, Sina, Christian, Sallese, Anthony et al. · 2018 · JCI Insight
77. Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease
    Jeongeun Mun, Shintae Kim, Ho‐Geun Yoon, Yanghee You, Ok‐Kyung Kim, Kyung‐Chul Choi, Yoo‐Hyun Lee, Jeongmin Lee, Jeongjin Park, Woojin Jun · 2019 · Nutrients
78. Glucose Transporter 8 (GLUT8) Mediates Fructose-induced de Novo Lipogenesis and Macrosteatosis
    Brian J. DeBosch, Zhouji Chen, Jessica L. Saben, Brian N. Finck, Kelle H. Moley · 2014 · Journal of Biological Chemistry
79. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment
    Zhang, Peng, Chen, Zhimin, Kuang, Henry, Liu, Tongyu, Zhu, Jiaqiang, Zhou, Linkang, Wang, Qiuyu, Xiong, Xuelian, Meng, Ziyi, Qiu, Xiaoxue et al. · 2022 · Cell Metabolism
80. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice
    Fatiha Nassir, Adewole L. Okunade, Elizabeth M. Brunt, Nada A. Abumrad · 2013 · Journal of Lipid Research
81. Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
    Wei Zhu, Sifan Chen, Zilun Li, Xiaohong Zhao, Wenxue Li, Yanshuang Sun, Zili Zhang, Wenhua Ling, Xiang Feng · 2014 · Nutrition & Metabolism
82. The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes
    Alexandre Gabarra Oliveira, Tiago Gomes Araújo, Bruno de Melo Carvalho, Guilherme Z. Rocha, Andrey Santos, Mário J.A. Saad · 2018 · Frontiers in Endocrinology
83. Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi
    Xiong, Xuelian, Wang, Qiuyu, Wang, Shuai, Zhang, Jinglong, Liu, Tongyu, Guo, Liang, Yu, Yonghao, Lin, Jiandie D. · 2019 · Molecular Metabolism
84. Pediatric NAFLD: an overview and recent developments in diagnostics and treatment
    Laura G. Draijer, Marc Alexander Benninga, Bart G.P. Koot · 2019 · Expert Review of Gastroenterology & Hepatology
85. A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption
    Hye Rim Jang, Hyun‐Jun Park, Dong‐Won Kang, Hayung Chung, Myung Hee Nam, Yeonhee Lee, Jae‐Hak Park, Hui‐Young Lee · 2019 · Experimental & Molecular Medicine
86. DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER
    Rong, Shunxing, Xia, Mingfeng, Vale, Goncalo, Wang, Simeng, Kim, Chai-Wan, Li, Shili, McDonald, Jeffrey G., Radhakrishnan, Arun, Horton, Jay D. · 2024 · Cell Metabolism
87. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
    Rebecca C. Schugar, Peter A. Crawford · 2012 · Current Opinion in Clinical Nutrition & Metabolic Care
88. NF-E2-Related Factor 1 (Nrf1) Serves as a Novel Regulator of Hepatic Lipid Metabolism through Regulation of the Lipin1 and PGC-1 β Genes
    Yosuke Hirotsu, Nami Hataya, Fumiki Katsuoka, Masayuki P. Yamamoto · 2012 · Molecular and Cellular Biology
89. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes
    Zobair M. Younossi, Priya Aggarwal, Ichhya Shrestha, João Diogo da Rocha Fernandes, Pierre Johansen, Margarida Augusto, Sunita Nair · 2022 · JHEP Reports
90. The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis
    Knorr, Jana, Wree, Alexander, Tacke, Frank, Feldstein, Ariel E. · 2020 · Seminars in Liver Disease
91. Targeted Disruption of G0/G1 Switch Gene 2 Enhances Adipose Lipolysis, Alters Hepatic Energy Balance, and Alleviates High-Fat Diet–Induced Liver Steatosis
    Xiaodong Zhang, Xitao Xie, Bradlee L. Heckmann, Alicia M. Saarinen, Traci A. Czyzyk, Jun Liu · 2013 · Diabetes
92. The New Face of the Lipid Droplet: Lipid Droplet Proteins
    Congyan Zhang, Pingsheng Liu · 2018 · PROTEOMICS
93. Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
    Meng Michelle Xu, Peter P. Liu, Hongliang Li · 2018 · Physiological Reviews
94. Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential
    Hai‐Jian Sun, Zhiyuan Wu, Xiao-Wei Nie, Xinyu Wang, Jin‐Song Bian · 2020 · Journal of Advanced Research
95. Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
    Yan Lu, Zhimin Ma, Zhijian Zhang, Xuelian Xiong, Xiaolin Wang, Huijie Zhang, Guojun Shi, Xuefeng Xia, Guang Ning, Xiaoying Li · 2013 · Gut
96. Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
    Barbara D. Pachikian, Ahmed Essaghir, Jean‐Baptiste Demoulin, Émilie Catry, Audrey M. Neyrinck, Evelyne M. Dewulf, Florence M. Sohet, Laurence Portois, Laure‐Alix Clerbaux, Yvon Carpentier et al. · 2012 · Molecular Nutrition & Food Research
97. PNPLA3/adiponutrin functions in lipid droplet formation
    Zeina Chamoun, Fabrizio Vacca, Robert G. Parton, Jean Grüenberg · 2013 · Biology of the Cell
98. Pioglitazone Upregulates Angiotensin Converting Enzyme 2 Expression in Insulin-Sensitive Tissues in Rats with High-Fat Diet-Induced Nonalcoholic Steatohepatitis
    Wei Zhang, Yi-Zhi Xu, Bo Liu, Rong Wu, Yingying Yang, Xiaoqiu Xiao, Xia Zhang · 2014 · The Scientific World JOURNAL
99. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
    Damien Viglino, Ingrid Jullian‐Desayes, Mélanie Minovès, Judith Aron‐Wisnewsky, Vincent Leroy, Jean‐Pierre Zarski, Renaud Tamisier, Marie Joyeux‐Faure, Jean‐Louis Pépin · 2017 · European Respiratory Journal
100. Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
     Fei Luo, Ēriks Šmagris, Sarah A. Martin, Goncalo Dias do Vale, Jeffrey G. McDonald, Justin A. Fletcher, Shawn C. Burgess, Helen H. Hobbs, Jonathan C. Cohen · 2021 · Cellular and Molecular Gastroenterology and Hepatology